A framework to guide dose & regimen strategy for clinical drug development
Abstract Optimizing new drug therapies remains a challenge for clinical development, despite the use of ever more sophisticated quantitative methodologies. Although conceptually simple, the idea of finding the right treatment at the right dose for the right patient to ensure an appropriate balance o...
Enregistré dans:
Auteurs principaux: | Oliver Sander, Baldur Magnusson, Inga Ludwig, Astrid Jullion, Christophe Meille, Daniel Lorand, Björn Bornkamp, Markus Hinder, Steven J. Kovacs, Michael Looby |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Wiley
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/15d1549b9b844cf58ce62297612b8cf4 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
A framework for economic evaluation of therapeutic drug monitoring—guided dosing in oncology
par: Daniel Erku, et autres
Publié: (2021) -
Evaluation framework to guide implementation of AI systems into healthcare settings
par: Enrico Coiera, et autres
Publié: (2021) -
Optimization of Initial Dose Regimen for Sirolimus in Pediatric Patients With Lymphangioma
par: Xiao Chen, et autres
Publié: (2021) -
Computed tomography-guided core needle biopsy for lung nodules: low-dose versus standard-dose protocols
par: Yi-Yang Huang, et autres
Publié: (2021) -
Regimen simplification and medication adherence: Fixed-dose versus loose-dose combination therapy for type 2 diabetes.
par: Anna-Katharina Böhm, et autres
Publié: (2021)